Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response

R Rosa1, O Roos Rodrigues, C Marques

  • 1Unidade de Leishmanioses e Centro de Malária e Outras Doenças Tropicais, Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa, Rua da Junqueira 96, 1349-008 Lisboa, Portugal.

Experimental Parasitology
|February 3, 2005
PubMed

Insights

Leishmania infantum proteins modulate host immunity differently in BALB/c and C57BL/6 mice. Protein fractions impact cytokine production (IL-4, IL-12), influencing parasite control based on host genetics and infection stage.

Area of Science:

  • Immunology
  • Parasitology
  • Molecular Biology

Background:

  • Leishmania infantum causes visceral leishmaniasis.
  • Host immune response and genetic background influence disease outcome.
  • Parasite-derived proteins may modulate host immunity.

Purpose of the Study:

  • To analyze the modulatory effect of Leishmania infantum promastigote-released proteins on the cellular immune response.
  • To investigate these effects in susceptible (BALB/c) and resistant (C57BL/6) mouse strains at different infection time points (30 and 45 days).

Main Methods:

  • Cultured Leishmania infantum promastigotes released protein fractions (High, Inter, Low).
  • Spleen cells from infected BALB/c and C57BL/6 mice were stimulated with these fractions.
  • Cell proliferation and cytokine expression (IL-4, IL-12) were analyzed.

Main Results:

  • In C57BL/6 mice, protein fractions stimulated spleen cell proliferation and cytokine expression.
  • In C57BL/6 mice, the Low protein fraction induced IL-4 release following parasite load decrease.
  • In BALB/c mice, specific immune responses were observed at higher parasitic loads, with Inter fraction promoting IL-4 and High/Low fractions inducing IL-12.

Conclusions:

  • Leishmania infantum protein fractions play a role in modulating host immunity.
  • The immune modulation depends on host genetic background and parasite load.
  • These proteins are critical in controlling parasite replication and preventing premature host death.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...